title: Country break-out session highlights.
abstract: Individuals with multiple sclerosis (MS) spasticity present a wide range of symptoms and disability levels that are frequently challenging to manage. At the MS Experts Summit 2015, five country breakout sessions were conducted in parallel, and mainly in the native language, to examine various aspects about the management of treatment-resistant MS spasticity. Topics covered included video documentation of MS spasticity management (Germany), use of cannabinoid medicines in daily practice (Italy), multidisciplinary approach to MS spasticity care (France), titration and adherence to treatments for MS spasticity (Spain) and management of MS symptoms (Norway/Rest of World). For the benefit of all attendees, session highlights were collated and presented in a Plenary Session which is summarized herein.
authors.affiliation: Department of Neurology, Medical University of Graz, Auenbruggerplatz 22, 8036 Graz, Austria.
authors.forename: Franz
authors.initials: F
authors.lastname: Fazekas
authors.affiliation: Neurozentrum am Klosterforst, Itzehoe, Germany.
authors.forename: Klaus
authors.initials: K
authors.lastname: Gehring
authors.affiliation: Department of Neurosciences, DNS University Hospital of Padua, Padua, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Gallo
authors.affiliation: Centre Hospitalier Universitaire, Nice, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Lebrun-Frénay
authors.affiliation: Department of Neurology, Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Spain.
authors.forename: Ester
authors.initials: E
authors.lastname: Moral
authors.affiliation: Department of Neurology, Haukeland University Hospital, & University of Bergen, Bergen, Norway.
authors.forename: Kjell-Morten
authors.initials: KM
authors.lastname: Myhr
mesh_terms: D006233:Persons with Disabilities; D019468:Disease Management; D005060:Europe / Q000453:epidemiology; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications / Q000453:epidemiology / Q000628:therapy; D009128:Muscle Spasticity / Q000453:epidemiology / Q000209:etiology / Q000628:therapy
keywords: THC:CBD oromucosal spray; gait disturbances; goals of therapy; multidisciplinary teams; multiple sclerosis; spasticity; symptom management